USFDA completes inspection at Lupin’s Nagpur Oral Solid Dosage Facility

13 Jul 2023 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Lupin’s Nagpur Oral Solid Dosage Facility from July 3, 2023 to July 11, 2023. The inspection closed with issuance of a Form-483 with two observations. 

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2139.40 -26.70 (-1.23%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×